# Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine

> **NCT02426905** · PHASE4 · UNKNOWN · sponsor: **Univar BV** · enrollment: 90 (estimated)

## Conditions studied

- Wilson Disease

## Interventions

- **DRUG:** trientine dihydrochloride

## Key facts

- **NCT ID:** NCT02426905
- **Lead sponsor:** Univar BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2018-05
- **Final completion:** 2018-07
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2017-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02426905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02426905, "Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02426905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*